Immuno Oncology Assays Market worth $7.9 billion by 2026 - Exclusive Report by MarketsandMarkets™
The consumables segment accounted for the largest share of the market in 2020.
- The consumables segment accounted for the largest share of the market in 2020.
- Unlike instruments, consumables require repeat purchase, which results in their stable demand among end users.\nThe immuno-oncology assays market is segmented into PCR, immunoassay, NGS, flow cytometry, and ISH based on technology.
- In 2020, the research applications segment accounted for the largest share of the market.
- The emergence of cancer immunotherapy is driving this segments growth.\nThe immuno-oncology assays market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.